Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 785

1.

EphA4 loss improves social memory performance and alters dendritic spine morphology without changes in amyloid pathology in a mouse model of Alzheimer's disease.

Poppe L, Rué L, Timmers M, Lenaerts A, Storm A, Callaerts-Vegh Z, Courtand G, de Boer A, Smolders S, Van Damme P, Van Den Bosch L, D'Hooge R, De Strooper B, Robberecht W, Lemmens R.

Alzheimers Res Ther. 2019 Dec 12;11(1):102. doi: 10.1186/s13195-019-0554-4.

2.

Lowering EphA4 Does Not Ameliorate Disease in a Mouse Model for Severe Spinal Muscular Atrophy.

Poppe L, Smolders S, Rué L, Timmers M, Lenaerts A, Storm A, Schoonaert L, de Boer A, Van Damme P, Van Den Bosch L, Robberecht W, Lemmens R.

Front Neurosci. 2019 Nov 19;13:1233. doi: 10.3389/fnins.2019.01233. eCollection 2019.

3.

RNA-Sequencing Highlights Inflammation and Impaired Integrity of the Vascular Wall in Brain Arteriovenous Malformations.

Hauer AJ, Kleinloog R, Giuliani F, Rinkel GJE, de Kort GA, Berkelbach van der Sprenkel JW, van der Zwan A, Gosselaar PH, van Rijen PC, de Boer-Bergsma JJ, Deelen P, Swertz MA, De Muynck L, Van Damme P, Veldink JH, Ruigrok YM, Klijn CJM.

Stroke. 2019 Dec 4:STROKEAHA119025657. doi: 10.1161/STROKEAHA.119.025657. [Epub ahead of print]

PMID:
31795902
4.

Circadian sleep/wake-associated cells show dipeptide repeat protein aggregates in C9orf72-related ALS and FTLD cases.

Dedeene L, Van Schoor E, Vandenberghe R, Van Damme P, Poesen K, Thal DR.

Acta Neuropathol Commun. 2019 Dec 2;7(1):189. doi: 10.1186/s40478-019-0845-9.

5.

Skin thickness measurements for optimal intradermal injections in children.

Van Mulder TJS, Van Nuffel D, Demolder M, De Meyer G, Moens S, Beyers KCL, Vankerckhoven VVJ, Van Damme P, Theeten H.

Vaccine. 2019 Nov 22. pii: S0264-410X(19)31509-9. doi: 10.1016/j.vaccine.2019.11.002. [Epub ahead of print]

PMID:
31767463
6.

Phenotypes and malignancy risk of different FUS mutations in genetic amyotrophic lateral sclerosis.

Naumann M, Peikert K, Günther R, van der Kooi AJ, Aronica E, Hübers A, Danel V, Corcia P, Pan-Montojo F, Cirak S, Haliloglu G, Ludolph AC, Goswami A, Andersen PM, Prudlo J, Wegner F, Van Damme P, Weishaupt JH, Hermann A.

Ann Clin Transl Neurol. 2019 Nov 4. doi: 10.1002/acn3.50930. [Epub ahead of print]

7.

C9orf72-generated poly-GR and poly-PR do not directly interfere with nucleocytoplasmic transport.

Vanneste J, Vercruysse T, Boeynaems S, Sicart A, Van Damme P, Daelemans D, Van Den Bosch L.

Sci Rep. 2019 Oct 31;9(1):15728. doi: 10.1038/s41598-019-52035-6.

8.

The effect of maternal antibodies on the cellular immune response after infant vaccination: A review.

Orije MRP, Maertens K, Corbière V, Wanlapakorn N, Van Damme P, Leuridan E, Mascart F.

Vaccine. 2020 Jan 3;38(1):20-28. doi: 10.1016/j.vaccine.2019.10.025. Epub 2019 Oct 28. Review.

PMID:
31672332
9.

A Phase 3 Multicenter, Prospective, Open-Label Efficacy and Safety Study of Immune Globulin (Human) 10% Caprylate/Chromatography Purified in Patients with Myasthenia Gravis Exacerbations.

Karelis G, Balasa R, De Bleecker JL, Stuchevskaya T, Villa A, Van Damme P, Lagrange E, Heckmann JM, Nicolle M, Vilciu C, Bril V, Mondou E, Griffin R, Chen J, Henriquez W, Garcia B, Camprubi S, Ayguasanosa J.

Eur Neurol. 2019;81(5-6):223-230. doi: 10.1159/000502818. Epub 2019 Oct 25.

PMID:
31655810
10.

Vaccination of healthcare personnel in Europe: Update to current policies.

Maltezou HC, Botelho-Nevers E, Brantsæter AB, Carlsson RM, Heininger U, Hübschen JM, Josefsdottir KS, Kassianos G, Kyncl J, Ledda C, Medić S, Nitsch-Osuch A, de Lejarazu RO, Theodoridou M, Van Damme P, van Essen GA, Wicker S, Wiedermann U, Poland GA; Vaccination Policies for HCP in Europe Study Group.

Vaccine. 2019 Dec 10;37(52):7576-7584. doi: 10.1016/j.vaccine.2019.09.061. Epub 2019 Oct 14.

PMID:
31623916
11.

Genetic diversity and structure of baobab (Adansonia digitata L.) in southeastern Kenya.

Chládová A, Kalousová M, Mandák B, Kehlenbeck K, Prinz K, Šmíd J, Van Damme P, Lojka B.

R Soc Open Sci. 2019 Sep 11;6(9):190854. doi: 10.1098/rsos.190854. eCollection 2019 Sep.

12.

Reducing EphA4 before disease onset does not affect survival in a mouse model of Amyotrophic Lateral Sclerosis.

Rué L, Timmers M, Lenaerts A, Smolders S, Poppe L, de Boer A, Van Den Bosch L, Van Damme P, Robberecht W, Lemmens R.

Sci Rep. 2019 Oct 1;9(1):14112. doi: 10.1038/s41598-019-50615-0.

13.

TSPO versus P2X7 as target for neuroinflammation - an in vitro and in vivo study.

Van Weehaeghe D, Van Schoor E, De Vocht J, Koole M, Attili B, Celen S, Declercq L, Thal DR, Van Damme P, Bormans G, Van Laere K.

J Nucl Med. 2019 Sep 27. pii: jnumed.119.231985. doi: 10.2967/jnumed.119.231985. [Epub ahead of print]

PMID:
31562223
14.

HPV vaccination: Are we overlooking additional opportunities to control HPV infection and transmission?

Vorsters A, Van Damme P, Bosch FX.

Int J Infect Dis. 2019 Nov;88:110-112. doi: 10.1016/j.ijid.2019.09.006. Epub 2019 Sep 12.

15.

HPV DNA detection in urine samples of women: 'an efficacious and accurate alternative to cervical samples?'

Pattyn J, Van Keer S, Téblick L, Van Damme P, Vorsters A.

Expert Rev Anti Infect Ther. 2019 Oct;17(10):755-757. doi: 10.1080/14787210.2019.1668776. Epub 2019 Sep 18. No abstract available.

PMID:
31519117
16.

Serum neurofilament heavy chains as early marker of motor neuron degeneration.

De Schaepdryver M, Goossens J, De Meyer S, Jeromin A, Masrori P, Brix B, Claeys KG, Schaeverbeke J, Adamczuk K, Vandenberghe R, Van Damme P, Poesen K.

Ann Clin Transl Neurol. 2019 Oct;6(10):1971-1979. doi: 10.1002/acn3.50890. Epub 2019 Sep 13.

17.

Differentiation but not ALS mutations in FUS rewires motor neuron metabolism.

Vandoorne T, Veys K, Guo W, Sicart A, Vints K, Swijsen A, Moisse M, Eelen G, Gounko NV, Fumagalli L, Fazal R, Germeys C, Quaegebeur A, Fendt SM, Carmeliet P, Verfaillie C, Van Damme P, Ghesquière B, De Bock K, Van Den Bosch L.

Nat Commun. 2019 Sep 12;10(1):4147. doi: 10.1038/s41467-019-12099-4.

18.

Infection and vaccine-induced HPV-specific antibodies in cervicovaginal secretions. A review of the literature.

Pattyn J, Van Keer S, Tjalma W, Matheeussen V, Van Damme P, Vorsters A.

Papillomavirus Res. 2019 Dec;8:100185. doi: 10.1016/j.pvr.2019.100185. Epub 2019 Sep 5. Review.

19.

Clinical trials with GMO-containing vaccines in Europe: Status and regulatory framework.

Kauffmann F, Van Damme P, Leroux-Roels G, Vandermeulen C, Berthels N, Beuneu C, Mali S.

Vaccine. 2019 Sep 30;37(42):6144-6153. doi: 10.1016/j.vaccine.2019.08.018. Epub 2019 Sep 4. Review.

PMID:
31493949
20.

Poliopolis: pushing boundaries of scientific innovations for disease eradication.

Van Damme P, Coster I, Bandyopadhyay AS, Suykens L, Rudelsheim P, Neels P, Oberste MS, Weldon WC, Clemens R, Revets H.

Future Microbiol. 2019 Sep 4. doi: 10.2217/fmb-2019-0196. [Epub ahead of print]

Supplemental Content

Loading ...
Support Center